Penumbra, Inc. (PEN)
NYSE: PEN · Real-Time Price · USD
358.44
-0.09 (-0.03%)
Jan 23, 2026, 9:31 AM EST - Market open
Penumbra Employees
Penumbra had 4,500 employees as of December 31, 2024. The number of employees increased by 300 or 7.14% compared to the previous year.
Employees
4,500
Change (1Y)
300
Growth (1Y)
7.14%
Revenue / Employee
$296,400
Profits / Employee
$36,450
Market Cap
14.04B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 4,500 | 300 | 7.14% |
| Dec 31, 2023 | 4,200 | 300 | 7.69% |
| Dec 31, 2022 | 3,900 | 100 | 2.63% |
| Dec 31, 2021 | 3,800 | 500 | 15.15% |
| Dec 31, 2020 | 3,300 | 600 | 22.22% |
| Dec 31, 2019 | 2,700 | 500 | 22.73% |
| Dec 31, 2018 | 2,200 | 500 | 29.41% |
| Dec 31, 2017 | 1,700 | 200 | 13.33% |
| Dec 31, 2016 | 1,500 | 400 | 36.36% |
| Dec 31, 2015 | 1,100 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Koninklijke Philips | 67,823 |
| Smith & Nephew | 18,060 |
| STERIS | 17,787 |
| Zimmer Biomet Holdings | 17,000 |
| Bruker | 11,396 |
| Bio-Rad Laboratories | 7,700 |
| Bio-Rad Laboratories | 7,700 |
| Globus Medical | 5,300 |
PEN News
- 39 minutes ago - Artisan Small Cap Fund Q4 2025 Portfolio Activity - Seeking Alpha
- 8 days ago - Boston Scientific to buy Penumbra in $14.5B deal to expand cardiovascular reach - Invezz
- 8 days ago - Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion. - Barrons
- 8 days ago - Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing' vascular segments - Market Watch
- 8 days ago - Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock - WSJ
- 8 days ago - Boston Scientific to buy Penumbra in deal valued at $14.5 billion - Reuters
- 8 days ago - Penumbra, Inc. Provides Preliminary Update on Fourth Quarter and Full Year 2025 Financial Results - PRNewsWire
- 8 days ago - Boston Scientific announces agreement to acquire Penumbra, Inc. - PRNewsWire